Distribution and prognostic role of HER2 status of circulating tumor cells (CTCs) and tumor-derived extracellular vesicles (tdEVs) in HER2-metastatic breast cancer (MBC) patients (pts)

被引：0
|
作者：
Nicolo, E. [1 ]
Munoz-Arcos, L. [1 ]
D'Amico, P. [2 ]
Zhang, Y. [2 ]
Gerratana, L. [3 ]
Serafini, M. [1 ]
Pontolillo, L. [4 ]
Strickland, K. [1 ]
Manai, M. [1 ]
Davis, A. A. [5 ]
Donahue, J. [1 ]
Liu, H. [2 ,6 ]
Gradishar, W. J. [2 ]
Shah, A. N. [2 ]
Curigliano, G. [7 ]
Reduzzi, C. [1 ]
Cristofanilli, M. [1 ]
机构：
[1] Weill Cornell Med, Med, New York, NY USA
[2] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Dept Med Hematol & Oncol, Chicago, IL USA
[3] CRO Aviano Ctr Riferimento Oncol IRCCS, Med Oncol, Aviano, Italy
[4] Fdn Policlin Univ Agostino Gemelli IRCCS, Dept Med Oncol, Rome, Italy
[5] Washington Univ, Sch Med St Louis, Med Dept, Div Hematol & Oncol, St Louis, MO USA
[6] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Dept Pharmacol, Chicago, IL USA
[7] IEO Ist Europeo Oncol, Early Drug Dev Innovat Therapies Div, Milan, Italy
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.09.607
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
431P
引用
收藏
页码：S363 / S363
页数：1
相关论文
共 50 条
  • [41] Targeting HER2 in patients with HER2-negative metastatic breast cancer with elevated serum levels of the HER2 extracellular domain and/or HER2-positive circulating tumor cells in the clinical routine
    Kurbacher, C. M.
    Quade, A.
    Kunstmann, G.
    Herz, S.
    Kurbacher, J. A.
    Warm, M. A.
    ANNALS OF ONCOLOGY, 2015, 26
  • [42] Metastatic patterns and outcomes by HER2 and hormone receptor (HR) status in patients (pts) with metastatic breast cancer (mBC)
    Yuan, Qianyu
    Castellanos, Emily
    Fidyk, Erin
    Schwed, Karen
    Estevez, Melissa
    Nemeth, Sheila
    Linzmayer, Robin
    Cohen, Aaron B.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [43] Successful targeting HER2 in heavily pretreated HER2-negative metastatic breast cancer patients presenting with elevated serum levels of the HER2 extracellular domain and/or HER2 overexpressing circulating tumor cells
    Kurbacher, C. M.
    Quade, A.
    Eichler, C.
    Kunstmann, G.
    Herz, S.
    Kurbacher, J. A.
    Warm, M. R.
    CANCER RESEARCH, 2016, 76
  • [44] Prognostic value of HER2-positive circulating tumor cells in patients with metastatic breast cancer
    Naoki Hayashi
    Seigo Nakamura
    Yasuharu Tokuda
    Yuji Shimoda
    Hiroshi Yagata
    Atsushi Yoshida
    Hidekazu Ota
    Gabriel N. Hortobagyi
    Massimo Cristofanilli
    Naoto T. Ueno
    International Journal of Clinical Oncology, 2012, 17 : 96 - 104
  • [45] Prospective Evaluation of Serum HER2 and HER2 Expression on Circulating Tumor Cells in Patients with Metastatic Breast Cancer within the DETECT Study
    Mueller, V
    Riethdorf, S.
    Rack, B.
    Janni, W.
    Fasching, P.
    Pantel, K.
    Gebauser, G.
    Solomayer, E.
    Aktas, B.
    Kasemier-Bauer, S.
    Fehm, T.
    CANCER RESEARCH, 2009, 69 (24) : 662S - 662S
  • [46] Prognostic value of HER2-positive circulating tumor cells in patients with metastatic breast cancer
    Hayashi, Naoki
    Nakamura, Seigo
    Tokuda, Yasuharu
    Shimoda, Yuji
    Yagata, Hiroshi
    Yoshida, Atsushi
    Ota, Hidekazu
    Hortobagyi, Gabriel N.
    Cristofanilli, Massimo
    Ueno, Naoto T.
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2012, 17 (02) : 96 - 104
  • [47] Efficacy it eribulin in patients (pts) with metastatic breast cancer (MBC): A pooled Analysis by HER2 and ER status
    Kaufman, Peter
    Twelves, Chris
    Cortes, Javier
    Vandat, Linda T.
    Olivo, Martin
    He, Yi
    Awada, Ahmad
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (26)
  • [48] Efficacy of eribulin in patients (pts) with metastatic breast cancer (MBC): a pooled analysis by HER2 and ER status
    Twelves, C.
    Cortes, J.
    Vahdat, L.
    Olivo, M.
    He, Y.
    Kaufman, P. A.
    Awada, A.
    ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 261 - 262
  • [49] Multiple Biomarker Expression in Circulating Tumor Cells (CTCs) from Metastatic Breast Cancer (MBC) Patients (Pts).
    Somlo, G.
    Hsieh, H. B.
    Curry, D. N.
    Frankel, P.
    Krivacic, R. T.
    Lau, S.
    Lazarus, N.
    Baker, N.
    Swain-Cabriales, S.
    Bruce, R.
    CANCER RESEARCH, 2009, 69 (24) : 649S - 649S
  • [50] Anti-HER2 treatment in advanced metastatic HER2-negative breast cancer patients with elevated serum levels of the HER2 extracellular domain and/or HER2 overexpressing circulating tumor cells.
    Kurbacher, Christian M.
    Eichler, Christian A.
    Quade, Annegret Barbara
    Kunstmann, Gerhard
    Herz, Susanne
    Kurbacher, Jutta Anna
    Warm, Mathias R.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
12345